Achieve Life Sciences, Inc. ACHV
7.54
(0.29)
(3.70%)
as of 25 Sep
- Market cap
- $814.0M
- P/E
- 0.0×
Follow ACHV
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
4.94 | 4.01 | 2.47 | 0.95 | |
Current Ratio |
5.14 | 4.39 | 2.62 | 0.95 | |
Net Debt/EBITDA |
2.61 | 1.36 | 1.38 | 9.34 | |
Debt/Assets |
19.14% | 39.51% | 45.17% | 8.57% | |
Debt/Equity |
0.30 | 0.77 | 1.40 | (1.11) | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.78 | 1.23 | 0.68 | 0.14 | |
Capex/Depreciation |
0.00 | (0.06) | 0.00 | (2.30) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.04 | 0.04 | 0.05 | 0.01 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.22) | (0.41) | (0.13) | (0.12) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.22) | (0.41) | (0.13) | (0.12) | |
Cash per Share |
0.94 | 0.84 | 0.55 | 2.00 | |
Shareholders Equity per Share |
0.66 | 0.49 | 0.20 | (0.16) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.66 | 0.49 | 0.20 | (0.16) | |
Free Cash Flow |
(11.33) | (17.98) | (6.93) | (10.96) | |
Working Capital |
40.33 | 30.81 | 19.23 | (9.36) | |
Capital Expenditures |
— | 0.00 | — | (0.19) | |
Net Current Asset Value |
31.63 | 19.62 | 8.63 | (16.82) | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
— | 0.00 | — | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Payables |
1.48 | 1.41 | 1.24 | 0.91 | |
Average Assets |
49.98 | 40.21 | 30.23 | 124.69 | |
Average Common Equity |
32.50 | 21.21 | 10.48 | 13.50 |
Columns are period end dates